Magazine

Magazine

Young People of Color As Leaders in The Movement To End the War on Drugs

How do you center the needs and perspectives of people of color in your activism—not because you want to fill a quota, but because the success of your work depends on it?

Magazine

Considerations for Engaging with Amazonian Ancestral Practices, People, and Places

If we truly believe in the positive transformational power of visionary plant experiences, we must support each other to make real social change happen, less this transformation stagnates at the individual level.

Magazine

Shipibo Women Healers on the Challenges and Opportunities of the Ayahuasca Boom

After the murder of a Peruvian healer in 2018, traditional healers, local political figures, and nonprofit allies gathered to address the complexities that come with the influx of foreigners seeking ayahuasca in the Amazon.

Magazine

Third Wave staff quits, writes open letter, over work environment created by founder Paul Austin

Eight staff have quit The Third Wave and issued an open statement.

Magazine

MDMA Expanded Access is almost here. What’s it all about?

The Multidisciplinary Association for Psychedelic Studies (MAPS) submitted their MDMA PTSD expanded access protocol to the FDA on January 14, 2019.

Magazine

This is what psychedelic mainstreaming looks like…in Arizona

As psychedelic medicalization and the potential profits of a “virgin market” loom large, new organizations are increasingly looking to gain legitimacy within the field. Mainstreaming means the doors of this field are being thrown wide open.

Magazine

Will MDMA-assisted psychotherapy be covered by health insurance?

Until MDMA-assisted psychotherapy is proven without a doubt to reduce long-term costs, many insurance companies do not have an incentive to cover it.

Magazine

How will MDMA be rescheduled in the future? You may be disappointed

What does MDMA rescheduling mean for the recreational user? If you are under the impression that MDMA is on its way to being rescheduled, across the board, you may be disappointed.

Magazine

The Future of MDMA: Phase 3 and Beyond

What does the future hold for MDMA? We explore MAPS’ ongoing FDA phase 3 clinical trials, rescheduling, health insurance, and expanded access.

Magazine

The First Step Act is not the criminal justice reform we need. But it’s a start.

Trump signed into law the First Step Act, which makes modest reforms that ease the federal prison population.

Magazine

Let’s Talk About Psychedelic-Induced Psychosis

Comedian Shane Mauss and Zendo Project’s Ryan Beauregard on psychedelic-induced psychosis. “It was really easy once I got past the big video game, ‘Truman Show’ feeling, to get to a place of, ‘oh, that was all in my head. I was crazy.’”

Magazine

The Bunk Police is looking to destroy dishonesty in the drug market

If there are other harm-reduction organizations, such as DanceSafe, that are able to distribute test kits, then we won’t attend that event….the ones that refuse DanceSafe, we come in and do it anyways.